Access Restricted for EU Residents
You are attempting to access a website operated by an entity not regulated in the EU. Products and services on this website do not comply with EU laws or ESMA investor-protection standards.
As an EU resident, you cannot proceed to the offshore website.
Please continue on the EU-regulated website to ensure full regulatory protection.
Tuesday Aug 25 2026 08:43
7 min


Unitree Robotics shares have fallen sharply after one of the most dramatic stock market debuts in China, as investors reassess the company’s valuation and the commercial prospects of humanoid robots.
The Hangzhou-based robotics company closed Monday at 603.08 yuan, approximately 45% below the intraday high of 1,100 yuan reached during its August 19 debut. The decline has erased more than 200 billion yuan from Unitree’s peak market value in less than a week.
Unitree’s first trading session had initially demonstrated extraordinary demand for Chinese robotics stocks. The shares opened 629% above their IPO price of 150.80 yuan and ended the day at 845 yuan, representing a first-day gain of roughly 460%.
Despite the subsequent sell-off, Unitree stock remains around four times its IPO price. Investors who received shares at the offer price are therefore still sitting on substantial gains, while those who purchased near the debut-day peak have experienced steep losses.
The rapid reversal shows how quickly sentiment can change when excitement surrounding an emerging technology collides with concerns about earnings, valuation and commercial adoption.
At its intraday peak, Unitree was valued at approximately 445 billion yuan, or around $66 billion. That briefly placed the company among China’s most valuable technology manufacturers, even though the humanoid robotics industry remains at an early stage of development.
By Monday’s close, Unitree’s market capitalisation had fallen to approximately 244 billion yuan. Although still a significant valuation, it reflects a much more cautious assessment of the company’s future growth.
The decline does not appear to have been driven by a single negative announcement. Instead, the sell-off represents a broader reassessment after the extreme first-day price increase.
When a newly listed stock rises several hundred per cent in one session, even modest concerns can trigger profit-taking. Early investors may choose to secure gains, while buyers who enter near the top can sell quickly when momentum begins to reverse.
Unitree’s limited publicly traded share supply may have intensified both movements. A small initial float contributed to scarcity during the debut, but it also left the stock vulnerable to sharp price changes once buying demand weakened.
Unitree entered the public market with stronger financial results than many early-stage humanoid robotics companies.
The company’s revenue increased more than fourfold to 1.7 billion yuan in 2025, supported by demand for its quadruped robots and humanoid platforms. Unitree was also profitable before its listing and raised approximately 6.1 billion yuan through the IPO.
However, its latest quarterly results highlighted the cost of maintaining rapid technological development. Adjusted profit for the first quarter fell by about 53% to approximately 40 million yuan as research, production and expansion expenses increased.
The decline in profit has become more important now that Unitree is publicly traded. Investors are no longer valuing the business solely on its engineering achievements or position within China’s robotics strategy. Revenue quality, profit margins, order visibility and operating cash flow are likely to receive greater attention.
Robotics manufacturers typically face high upfront costs. Developing motors, sensors, control systems and artificial intelligence software requires sustained investment, while mass production can create additional spending on factories and supply chains.
Unitree must therefore demonstrate that rising robot shipments can eventually produce stronger and more consistent earnings.
Unitree shipped more than 5,500 humanoid robots in 2025, placing it among the world’s largest suppliers. Nevertheless, shipments do not automatically translate into widespread commercial deployment.
Many humanoid robots are currently purchased for research, demonstrations, education and limited industrial testing. These applications help manufacturers improve their technology but may not generate the recurring demand required to support very high valuations.
Unitree founder Wang Xingxing has acknowledged that humanoid robots are not yet ready for broad factory use. Current models can be less efficient than human workers when performing simple tasks and may struggle to adapt their learned abilities across different environments.
These limitations create uncertainty over when humanoid robots will become economically competitive in factories, warehouses and service industries.
Artificial intelligence capability remains another important factor. Robots need to understand their surroundings, make decisions and complete unfamiliar tasks safely. Without substantial improvements in AI models, growth in humanoid shipments could slow after the current wave of corporate trials and research demand.
Unitree’s IPO attracted extraordinary interest from individual investors. Nearly 9.8 million retail accounts competed for approximately 9.7 million shares in the online portion of the offering.
That level of demand meant there was roughly one available share for each participating account. The imbalance helped push the stock far above its issue price immediately after trading began.
China’s IPO structure may also have contributed to the extreme price movement. Regulatory oversight can result in conservative offer prices, while the limited number of shares available during the initial listing creates additional scarcity.
Restrictions affecting short selling can make the imbalance stronger. Investors who believe a newly listed company is overvalued have fewer opportunities to express that view, allowing enthusiastic buyers to dominate early trading.
However, those conditions can reverse once the initial demand is exhausted. Investors who receive shares at the IPO price may take profits, while buyers entering after a large opening surge face considerably greater downside risk.
Unitree’s fall from 1,100 yuan to 603.08 yuan illustrates this difference. The stock is still substantially above the offer price, but it has generated significant losses for investors who purchased during the peak of the debut-day frenzy.
Unitree’s stock volatility is likely to be closely watched across China’s broader robotics sector.
Beijing has identified embodied artificial intelligence and advanced robotics as strategic industries. Government support, private investment and rapid improvements in domestic supply chains have helped Chinese companies become major competitors in robot manufacturing.
Unitree retains several potential strengths, including relatively fast product development, established production capability and an early position in both quadruped and humanoid robots.
However, public-market investors are increasingly focused on whether these technological advantages can translate into sustainable commercial orders. Future share-price performance may depend on shipment growth, customer adoption, production costs and whether Unitree can stabilise its profit margins.
The company’s first week on the STAR Market suggests enthusiasm for China’s robotics industry remains strong. It also demonstrates that policy support and technological spectacle may not be sufficient to maintain an elevated valuation without clearer evidence of profitable, large-scale deployment.
Risk Warning: This article is provided for informational purposes only and does not constitute investment advice, investment research, or a recommendation to trade. The views expressed are those of the author and do not necessarily reflect the position of Markets.com. When considering shares, indices, forex (foreign exchange), and commodities for trading and price predictions, remember that trading CFDs involves a significant degree of risk and may not be suitable for all investors. Leveraged products can result in capital loss. Past performance is not indicative of future results. Before trading, ensure you fully understand the risks involved and consider your investment objectives and level of experience. Cryptocurrency CFD trading restrictions may apply depending on jurisdiction.